Unlocking the Full Potential of Oral Semaglutide: Cardio-Kidney-Metabolic Benefits – CME by Novo Nordisk

Dr. Sudhir Bhandari contributed to the academic programme at CME by Novo Nordisk with a session focused on Unlocking the Full Potential of Oral Semaglutide: Cardio-Kidney-Metabolic Benefits.

Programme: CME by Novo Nordisk
Academic Focus: Unlocking the Full Potential of Oral Semaglutide: Cardio-Kidney-Metabolic Benefits